DepoMed, Inc. (DEPO) Misses Q2 EPS by 6c
Tweet
Share
E-mailGet Alerts DEPO Hot Sheet
Price: $7.30 --0%
Financial Fact:
Net income (loss): -12.89M
Today's EPS Names:
DTGI, CRMT, STZ, More
Financial Fact:
Net income (loss): -12.89M
Today's EPS Names:
DTGI, CRMT, STZ, More
Join SI Premium – FREE
DepoMed, Inc. (NASDAQ: DEPO) reported Q2 EPS of ($0.11), $0.06 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $21.22 million versus the consensus estimate of $22.13 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Concentrix Corporation (CNXC) Misses Q2 EPS by 1c; Guides lower than expectations
- Apogee Enterprises (APOG) Tops Q1 EPS by 16c, Beats on Revenue; Offers FY27 Guidance
- Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
